StockData
Prelude Therapeutics Inc logo

Prelude Therapeutics Inc (PRLD) stock

PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3055% above fair value
$3.30−0.02 (-0.60%)

Close on Nov 18, 2026Market cap $263.35MP/E –Yield –

Prelude Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Prelude Therapeutics's market cap was $318.23M on Nov 11, 2026, against $127.67M a year earlier. Over the last 5 years it ranged from $57.54M to $471.45M, with a median of $232.66M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$318.23M+44.4%
2025Dec 31, 2025$220.39M+132.8%
2024Dec 31, 2024$94.65M-59.6%
2023Dec 29, 2023$234.11M-17.7%
2022Dec 30, 2022$284.59M+96.2%
2021Jan 29, 2021$145.04M-9.2%
2020Dec 31, 2020$159.77M–

More Prelude Therapeutics figures

See a number that looks wrong?